A Phase 2, Multicenter, Randomized Open-Label Study to Determine the Efficacy of Lenalidomide (Revlimid®) Versus Investigator's Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Update Il y a 4 ans
Reference: DRKS00003810

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract


Inclusion criteria

  • C83.1 - Non-Hodgkin's lymphoma: Small cleaved cell (diffuse),Mantle Cell Lymphoma # Lymphoma, Mantle-Cell

Links